<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Drug Therapy | FORRT - Framework for Open and Reproducible Research Training</title><link>https://forrt.org/tag/drug-therapy/</link><atom:link href="https://forrt.org/tag/drug-therapy/index.xml" rel="self" type="application/rss+xml"/><description>Drug Therapy</description><generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><copyright>Â© 2023 - FORRT Framework for Open and Reproducible Research Training</copyright><image><url>https://forrt.org/img/FORRT_banner.svg</url><title>Drug Therapy</title><link>https://forrt.org/tag/drug-therapy/</link></image><item><title>Likelihood of Null Effects of Large NHLBI Clinical Trials Has Increased over Time</title><link>https://forrt.org/curated_resources/699_likelihood-of-null-effects-of-large-nhlb/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://forrt.org/curated_resources/699_likelihood-of-null-effects-of-large-nhlb/</guid><description/></item><item><title>Open Access Target Validation Is a More Efficient Way to Accelerate Drug Discovery</title><link>https://forrt.org/curated_resources/715_open-access-target-validation-is-a-more/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://forrt.org/curated_resources/715_open-access-target-validation-is-a-more/</guid><description/></item><item><title>The Economics of Reproducibility in Preclinical Research</title><link>https://forrt.org/curated_resources/834_the-economics-of-reproducibility-in-prec/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://forrt.org/curated_resources/834_the-economics-of-reproducibility-in-prec/</guid><description/></item></channel></rss>